517920-69-3

Usage

Uses

Used in Pharmaceutical Synthesis:
5-Bromo-2,3-diaminofluorobenzene is used as a key intermediate in the synthesis of pharmaceutical products due to its ability to be readily incorporated into complex organic molecules, enhancing their therapeutic properties.
Used in Agrochemical Production:
In the agrochemical industry, 5-Bromo-2,3-diaminofluorobenzene is utilized as a building block for the development of new agrochemicals, contributing to the creation of more effective and targeted pest control agents.
Used in Dye Manufacturing:
5-Bromo-2,3-diaminofluorobenzene is employed as a precursor in the production of dyes, where its chemical structure allows for the creation of dyes with specific color characteristics and properties.
Used in Organic Chemistry as a Reagent:
5-BROMO-2,3-DIAMINOFLUOROBENZENE serves as a valuable reagent in organic chemistry reactions, facilitating the synthesis of a wide range of organic compounds through its reactive functional groups.
Used in Research for Biological and Pharmacological Activities:
5-Bromo-2,3-diaminofluorobenzene is used in research settings to explore its potential biological and pharmacological activities, which may lead to the discovery of new therapeutic agents or chemical processes.

InChI:InChI=1/C6H6BrFN2/c7-3-1-4(8)6(10)5(9)2-3/h1-2H,9-10H2

Upstream product

• 517920-70-6 4-Bromo-2-fluoro-6-nitrobenzenamine 
• 1193385-18-0 2-amino-4-bromo-6-fluoro-nitrobenzene 

Downstream Products

• 1210048-05-7 7-bromo-5-fluoroquinoxaline 
• 1242088-28-3 C₃₆H₄₁FN₆O₄ 
• 1197944-23-2 6-bromo-4-fluoro-1H-benzo[d]imidazole 

Relevant academic research and scientific papers

Aromatic-ring-containing compound, preparation method thereof, pharmaceutical composition and application thereof

The invention discloses an aromatic-ring-containing compound, a preparation method thereof, a pharmaceutical composition and application. The present invention provides the aromatic-ring-containing compound represented by a formula 1, a pharmaceutically acceptable salt thereof, a stereoisomer thereof, a tautomer thereof or a solvate thereof, and the aromatic-ring-containing compound can be effectively bounded to bromodomains of BRD4, BRD3, BRD2, and BRDT in BET family to regulate transcription of downstream gene c-myc and related target genes of the c-myc so as to regulate downstream signalingpathways to play specific roles including treatment of diseases such as inflammatory diseases, cancer, and AIDS. Some of the compounds have high activity, and have good cell activity and metabolic stability, so that the compounds can be an effective drug for treating tumors.

ANTI-VIRAL COMPOUNDS

Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.

SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF

The present application relates to novel substituted 5-aminopyrazoles, methods of production thereof, use thereof alone or in combinations for the treatment and/or prophylaxis of diseases and use thereof for the production of medicinal products for the treatment and/or prophylaxis of diseases.

BENZOIMIDAZOLES AS PROLYL HYDROXYLASE INHIBITORS

The present invention is directed to benzoimidazole compounds of the formula (1) and enantiomers, diastereomers, racemates, and pharmaceutically acceptable salts thereof. Compounds of the present invention are useful in pharmaceutical compositions and met

Benzimidazole- and benzoxazole-based inhibitors of Rho kinase

Inhibitors of Rho kinase have been developed based on two distinct scaffolds, benzimidazoles, and benzoxazoles. SAR studies and efforts to optimize the initial lead compounds are described. Novel selective inhibitors of ROCK-II with excellent potency in b